Current state and prospects of biotechnology in Central and Eastern European countries. Part II: new and preaccession EU countries(CRO, RO, B&H, SRB)
Само за регистроване кориснике
2019
Аутори
Dettenhofer, MarkusOndrejovič, Miroslav
Slavica, Anita
Kurtanjek, Želimir
Tapaloaga, Dana
Rodian Tapaloaga, Paul
Kapur Pojskić, Lejla
Durmić-Pašić, Adaleta
Begović, Jelena
Nedović, Viktor
Dundar, Munis
Gartland, Kevan M. A.
Miertuš, Stanislav
Чланак у часопису (Објављена верзија)
Метаподаци
Приказ свих података о документуАпстракт
Innovation holds the potential for economic prosperity. Biotechnology (BT) has proved to be a viable vehicle for the development and utilization of technologies, which has brought not only advances to society, but also career opportunities to nation-states that have enabling conditions. In this review, we assess the current state of BT-related activities within selected new and preaccession EU countries (NPA) of CEE region namely Croatia, Romania, Bosnia and Herzegovina and Serbia, examining educational programs, research activity, enterprises, and the financing systems. The field of BT covers a broad area of activities, including medical, food and agriculture, aquaculture or marine, environmental, biofuels, bioinformatics, and many others. Under the European Commission (EC), member-states are to set their Research and Innovation Strategies for Smart Specialization (RIS3), to identify priorities or strengths in order to develop knowledge intensive economies. As the four countries highl...ighted in this review are in the early stages of implementing RIS3 or have not yet fully formulated, it presents an opportunity to learn from the successes and failures of those that have already received major structural funds from the EC. A critical point will be the ability of the public and private sectors’ actors to align, in the implementation of RIS3 as new investment instruments emerge, and to concentrate efforts on a few select target goals, rather than distribute funding widely without respect to a long-term vision.
Кључне речи:
Biotechnology (BT) / Central and Eastern Europe (CEE) / higher education / New and preaccession EU countries (NPA) / public financing science / research and innovation (R&I) / small and medium enterprise (SME) / Smart Specialization Strategy (RIS3)Извор:
Critical Reviews in Biotechnology, 2019, 39, 1, 137-155Финансирање / пројекти:
- This work was supported by the Slovak Research and Development Agency grants APVV-14–0294, APVV-14-0393, APVV-15–0111, APVV-16–0088 and APVV-17-0239 and Agentura na Podporu Vyskumu a Vyvoja.
DOI: 10.1080/07388551.2018.1498443
ISSN: 0738-8551; 1549-7801(Online)
WoS: 000451853600009
Scopus: 2-s2.0-85052909304
URI
https://doi.org/10.1080/07388551.2018.1498443https://imagine.imgge.bg.ac.rs/handle/123456789/2193
Институција/група
Institut za molekularnu genetiku i genetičko inženjerstvoTY - JOUR AU - Dettenhofer, Markus AU - Ondrejovič, Miroslav AU - Slavica, Anita AU - Kurtanjek, Želimir AU - Tapaloaga, Dana AU - Rodian Tapaloaga, Paul AU - Kapur Pojskić, Lejla AU - Durmić-Pašić, Adaleta AU - Begović, Jelena AU - Nedović, Viktor AU - Dundar, Munis AU - Gartland, Kevan M. A. AU - Miertuš, Stanislav PY - 2019 UR - https://doi.org/10.1080/07388551.2018.1498443 UR - https://imagine.imgge.bg.ac.rs/handle/123456789/2193 AB - Innovation holds the potential for economic prosperity. Biotechnology (BT) has proved to be a viable vehicle for the development and utilization of technologies, which has brought not only advances to society, but also career opportunities to nation-states that have enabling conditions. In this review, we assess the current state of BT-related activities within selected new and preaccession EU countries (NPA) of CEE region namely Croatia, Romania, Bosnia and Herzegovina and Serbia, examining educational programs, research activity, enterprises, and the financing systems. The field of BT covers a broad area of activities, including medical, food and agriculture, aquaculture or marine, environmental, biofuels, bioinformatics, and many others. Under the European Commission (EC), member-states are to set their Research and Innovation Strategies for Smart Specialization (RIS3), to identify priorities or strengths in order to develop knowledge intensive economies. As the four countries highlighted in this review are in the early stages of implementing RIS3 or have not yet fully formulated, it presents an opportunity to learn from the successes and failures of those that have already received major structural funds from the EC. A critical point will be the ability of the public and private sectors’ actors to align, in the implementation of RIS3 as new investment instruments emerge, and to concentrate efforts on a few select target goals, rather than distribute funding widely without respect to a long-term vision. T2 - Critical Reviews in Biotechnology T2 - Critical Reviews in Biotechnology T1 - Current state and prospects of biotechnology in Central and Eastern European countries. Part II: new and preaccession EU countries(CRO, RO, B&H, SRB) EP - 155 IS - 1 SP - 137 VL - 39 DO - 10.1080/07388551.2018.1498443 ER -
@article{ author = "Dettenhofer, Markus and Ondrejovič, Miroslav and Slavica, Anita and Kurtanjek, Želimir and Tapaloaga, Dana and Rodian Tapaloaga, Paul and Kapur Pojskić, Lejla and Durmić-Pašić, Adaleta and Begović, Jelena and Nedović, Viktor and Dundar, Munis and Gartland, Kevan M. A. and Miertuš, Stanislav", year = "2019", abstract = "Innovation holds the potential for economic prosperity. Biotechnology (BT) has proved to be a viable vehicle for the development and utilization of technologies, which has brought not only advances to society, but also career opportunities to nation-states that have enabling conditions. In this review, we assess the current state of BT-related activities within selected new and preaccession EU countries (NPA) of CEE region namely Croatia, Romania, Bosnia and Herzegovina and Serbia, examining educational programs, research activity, enterprises, and the financing systems. The field of BT covers a broad area of activities, including medical, food and agriculture, aquaculture or marine, environmental, biofuels, bioinformatics, and many others. Under the European Commission (EC), member-states are to set their Research and Innovation Strategies for Smart Specialization (RIS3), to identify priorities or strengths in order to develop knowledge intensive economies. As the four countries highlighted in this review are in the early stages of implementing RIS3 or have not yet fully formulated, it presents an opportunity to learn from the successes and failures of those that have already received major structural funds from the EC. A critical point will be the ability of the public and private sectors’ actors to align, in the implementation of RIS3 as new investment instruments emerge, and to concentrate efforts on a few select target goals, rather than distribute funding widely without respect to a long-term vision.", journal = "Critical Reviews in Biotechnology, Critical Reviews in Biotechnology", title = "Current state and prospects of biotechnology in Central and Eastern European countries. Part II: new and preaccession EU countries(CRO, RO, B&H, SRB)", pages = "155-137", number = "1", volume = "39", doi = "10.1080/07388551.2018.1498443" }
Dettenhofer, M., Ondrejovič, M., Slavica, A., Kurtanjek, Ž., Tapaloaga, D., Rodian Tapaloaga, P., Kapur Pojskić, L., Durmić-Pašić, A., Begović, J., Nedović, V., Dundar, M., Gartland, K. M. A.,& Miertuš, S.. (2019). Current state and prospects of biotechnology in Central and Eastern European countries. Part II: new and preaccession EU countries(CRO, RO, B&H, SRB). in Critical Reviews in Biotechnology, 39(1), 137-155. https://doi.org/10.1080/07388551.2018.1498443
Dettenhofer M, Ondrejovič M, Slavica A, Kurtanjek Ž, Tapaloaga D, Rodian Tapaloaga P, Kapur Pojskić L, Durmić-Pašić A, Begović J, Nedović V, Dundar M, Gartland KMA, Miertuš S. Current state and prospects of biotechnology in Central and Eastern European countries. Part II: new and preaccession EU countries(CRO, RO, B&H, SRB). in Critical Reviews in Biotechnology. 2019;39(1):137-155. doi:10.1080/07388551.2018.1498443 .
Dettenhofer, Markus, Ondrejovič, Miroslav, Slavica, Anita, Kurtanjek, Želimir, Tapaloaga, Dana, Rodian Tapaloaga, Paul, Kapur Pojskić, Lejla, Durmić-Pašić, Adaleta, Begović, Jelena, Nedović, Viktor, Dundar, Munis, Gartland, Kevan M. A., Miertuš, Stanislav, "Current state and prospects of biotechnology in Central and Eastern European countries. Part II: new and preaccession EU countries(CRO, RO, B&H, SRB)" in Critical Reviews in Biotechnology, 39, no. 1 (2019):137-155, https://doi.org/10.1080/07388551.2018.1498443 . .